Device Trauma & Extremities

Aequalis Ascend Flex

Payments companies reported to CMS as associated with Aequalis Ascend Flex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$848Kassociated payments (2023-2025)
1,344clinicians with associated payments
1company reporting

By year

2023 $396K
2024 $234K
2025 $218K

Payments reported as associated with Aequalis Ascend Flex, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $659K
Sports Medicine (Orthopaedic Surgery) $95K
Adult Reconstructive Orthopaedic Surgery $41K
Physician Assistant $7,941
Orthopaedic Trauma $6,246
Hand Surgery $5,711

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Aequalis Ascend Flex

These are the largest totals companies reported as associated with Aequalis Ascend Flex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Khazzam Grapevine, TX Orthopaedic Surgery $169,230.44
Eddie Lo Dallas, TX Orthopaedic Surgery $61,690.77
Brent Morris Lexington, KY Orthopaedic Surgery $45,014.66
Matthew Willis Nashville, TN Orthopaedic Surgery $35,162.09
Mark Mighell Temple Terrace, FL Orthopaedic Surgery $30,204.45
Armodios Hatzidakis Denver, CO Adult Reconstructive Orthopaedic Surgery $26,123.50
Albert Lin Pittsburgh, PA Sports Medicine (Orthopaedic Surgery) $20,994.47
Jamie Lynch San Antonio, TX Sports Medicine (Orthopaedic Surgery) $19,828.50
Tom Norris San Francisco, CA Orthopaedic Surgery $18,442.98
Joaquin Sanchez-Sotelo Rochester, MN Orthopaedic Surgery $16,950.31

Prescribed Aequalis Ascend Flex?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.